NCT03170960 2025-08-17Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsExelixisPhase 1 Active not recruiting914 enrolled
NCT04084951 2023-04-14Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsSQZ BiotechnologiesPhase 1 Completed30 enrolled
NCT02410512 2022-04-01A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Completed610 enrolled
NCT01633970 2020-10-08A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Completed240 enrolled
NCT01375842 2018-12-11A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Completed661 enrolled
NCT01688206 2018-10-05A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid TumorsHoffmann-La RochePhase 1 Completed132 enrolled
NCT02543645 2018-04-30A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerCelldex TherapeuticsPhase 1 Terminated18 enrolled